| Location |
Seoul/Busan, South Korea |
| Type |
National Research Institute |
| Founded |
1989 |
| Website |
kbri.re.kr |
| Focus Areas |
Brain Science, Neurodegeneration, Tauopathies, Biomarkers |
The Korea Brain Research Institute (KBRI, 한국뇌연구소) is South Korea's premier national research institute dedicated to brain science and neuroscience research. Established in 1989, KBRI operates under the auspices of the Korea Basic Science Institute and serves as the nation's flagship center for fundamental and translational neuroscience research.
KBRI has become increasingly important in neurodegenerative disease research, with particular focus on tauopathies including progressive supranuclear palsy (PSP), Alzheimer's disease, and Parkinson's disease. The institute coordinates national research initiatives and maintains collaborations with leading universities and hospitals across Korea.
KBRI was founded in 1989 as part of Korea's national research infrastructure expansion. Over the decades, the institute has grown from a small research center into a comprehensive neuroscience research hub.
- 1989: Founded as Korea Brain Research Institute
- 2000: Designated as national research institute
- 2010: Expanded research programs in neurodegenerative disease
- 2015: Launched Korea Brain Project
- 2020: Advanced tau imaging and biomarker programs
- 2023: Established national neurodegeneration research network
KBRI conducts extensive research on neurodegenerative diseases:
Tauopathies
- PSP pathology and biomarkers
- Tau PET tracer development and validation
- 4R-tau mechanisms in neurodegeneration
Alzheimer's Disease
- Amyloid and tau pathology
- Neuroinflammation mechanisms
- Biomarker development
Parkinson's Disease
- Alpha-synuclein research
- Genetic studies in Korean populations
- Motor and non-motor manifestations
The institute contributes to international brain mapping initiatives:
- Neural circuit mapping
- Connectomics projects
- Brain atlases for Korean populations
- AI and machine learning applications
- Neural network modeling
- Big data analysis platforms
KBRI researchers have been instrumental in advancing tau PET imaging in Asian populations:
- [^11C]PBB3 validation studies
- [^18F]APN-1607 clinical trials
- Cross-ethnic comparison of tracer binding
The institute has contributed significantly to biomarker research:
- Blood-based biomarkers for AD and PD
- CSF biomarker validation
- Multi-marker panels for early detection
Research on neuroinflammation in Korean populations:
- Microglial activation markers
- Inflammatory cytokine profiles
- Therapeutic targets
KBRI coordinates genetic research on neurodegenerative diseases:
- MAPT haplotype studies
- Population-specific variants
- International consortium participation
- International PSP Genetics Consortium
- Alzheimer's Disease Neuroimaging Initiative (ADNI)
- Michael J. Fox Foundation programs
- Human Brain Project (EU)
- Seoul National University
- Samsung Medical Center
- Korean Dementia Association
- Korea National Institute of Health
- PET/CT scanners
- 7T MRI
- Super-resolution microscopy
- Electron microscopy
- Molecular biology core
- Cell culture facility
- Proteomics platform
- Genomics center
- Korean Brain Bank
- Clinical database
- Imaging repository
The Korea Brain Project is a national initiative coordinated by KBRI:
- Brain mapping and connectomics
- Brain-inspired AI research
- Novel therapeutics development
- Neurotechnology development
KBRI leads a national network coordinating neurodegeneration research:
- Multi-center clinical studies
- Shared biobank resources
- Collaborative preclinical research
- Tau pathology research in Korean PSP patients (2024)
- Neuroinflammation in Korean neurodegenerative disease cohorts (2023)
- MAPT genetic variation in East Asian populations (2024)
- Blood biomarkers for neurodegenerative diseases in Korean populations (2024)
KBRI provides training opportunities:
- Postdoctoral fellowships
- Graduate student programs
- International visitor programs
- Technical workshops
-
Precision Medicine
- Population-specific biomarkers
- Personalized therapeutic approaches
-
Tau-Targeting
- Novel tracer development
- Therapeutic trials
-
AI Integration
- Diagnostic algorithms
- Drug discovery platforms
-
Regenerative Medicine
- Stem cell research
- Gene therapy development